Scienmag
JUNE 20, 2021
By identifying one of the mechanisms regulating the virulence of Pseudomonas aeruginosa, a UNIGE team is proposing a new strategy to combat this bacterium, which is resistant to many common antibiotics Credit: © UNIGE Pseudomonas aeruginosa is an opportunistic pathogenic bacterium present in many ecological niches, such as plant roots, stagnant water (..)
The Pharma Data
JUNE 14, 2023
Scientists discover small RNA that regulates bacterial infection People with weakened immune systems are at constant risk of infection. Further tests showed that the gene also regulates bacterial respiration under low oxygen conditions. Now, we know that oxygen levels are regulating this transition.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
NOVEMBER 23, 2023
This persistent strain of Salmonella , also known as REPJFX01, not only led to significant illnesses but also prompted a massive recall and stricter regulations on poultry processing. The scandal led to stricter regulations on pesticide use and a push for organic farming methods.
XTalks
APRIL 17, 2023
While food safety regulations and advances in technology have greatly reduced the incidence of such events, some of the worst food safety incidents continue to occur. The outbreak was caused by the bacterium Escherichia coli O157:H7, a strain of E. It was caused by a strain of E. coli known as E.
Pharma in Brief
NOVEMBER 20, 2023
The Courts’ decisions provide insight into how natural health products are distinguished, under federal law, from cosmetics and from drugs subject to the Food and Drug Regulations. These distinctions are important as they determine the regulatory burden required to market a product in Canada.
pharmaphorum
DECEMBER 4, 2020
Subject to approval from regulators the vaccine specialist said it plans the trial known as VLA15-221 as a randomised, observer-blind phase 2 study including around 600 healthy people aged 5-65 years of age. OspA is one of the most dominant surface proteins expressed by the bacteria when present in the ticks that spread the disease.
pharmaphorum
SEPTEMBER 8, 2022
The data from the ongoing study hasn’t yet been made public, but an interim analysis was enough to convince the US regulator that Pfizer’s GBS6 (PF-06760805) should be granted the designation, which could accelerate its passage through regulatory review. It has previously also been given fast-track status.
Expert insights. Personalized for you.
81 
Let's personalize your content